BIOMAT Database Logo BIOMAT Database Logo

Integrin mediated adhesion of mononuclear cells from patients with familial hypercholesterolemia. 1999

N de Bont, and T B Geijtenbeek, and M G Netea, and T J Smilde, and P N Demacker, and C G Figdor, and J W Van Der Meer, and A F Stalenhoef
Department of General Internal Medicine, University Hospital Nijmegen, The Netherlands.

BACKGROUND Low-density lipoproteins (LDL) can induce the adhesion of monocytes to endothelial cells. Monocytes of patients with familial hypercholesterolemia (FH) are exposed to high concentrations of LDL, and it has been reported that adhesiveness of these cells in hypercholesterolemic patients is enhanced. We investigated whether LFA-1 or VLA-4 mediated adhesion is altered in FH patients and whether HMG-CoA reductase inhibitors influence this adhesion. METHODS LFA-1 and VLA-4 mediated adhesion to ICAM-1 and VCAM-1 coated beads was investigated using freshly isolated monocytes and T-lymphocytes from patients with homozygous FH, heterozygous FH (before and after cholesterol lowering treatment), and from controls. In addition, the expression of beta1- and beta2-integrins on these cells was determined. RESULTS Both LFA-1 and VLA-4 mediated adhesion and integrin expression of monocytes and CD3+ cells from patients with homozygous FH and heterozygous FH was similar to that of monocytes from a control population. Treatment with HMG-CoA reductase inhibitors did not affect the adherence to ICAM-1 or VCAM-1, and did not influence the expression of integrins. CONCLUSIONS In contrast to studies by others, we demonstrated in the present study that the actual LFA-1 and VLA-4 mediated adhesion of T-lymphocytes and monocytes is not altered in patients with FH.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D005260 Female Females
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006720 Homozygote An individual in which both alleles at a given locus are identical. Homozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006938 Hyperlipoproteinemia Type II A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins). Hyperbetalipoproteinemia,Hypercholesterolemia, Essential,Hypercholesterolemia, Familial,Apolipoprotein B-100, Familial Defective,Apolipoprotein B-100, Familial Ligand-Defective,Familial Combined Hyperlipoproteinemia,Hyper-Low Density Lipoproteinemia,Hyper-Low-Density-Lipoproteinemia,Hyper-beta-Lipoproteinemia,Hypercholesterolemia, Autosomal Dominant,Hypercholesterolemia, Autosomal Dominant, Type B,Hypercholesterolemic Xanthomatosis, Familial,Hyperlipoproteinemia Type 2,Hyperlipoproteinemia Type IIa,Hyperlipoproteinemia Type IIb,Hyperlipoproteinemia, Type II,Hyperlipoproteinemia, Type IIa,LDL Receptor Disorder,Apolipoprotein B 100, Familial Defective,Apolipoprotein B 100, Familial Ligand Defective,Autosomal Dominant Hypercholesterolemia,Autosomal Dominant Hypercholesterolemias,Combined Hyperlipoproteinemia, Familial,Combined Hyperlipoproteinemias, Familial,Density Lipoproteinemia, Hyper-Low,Density Lipoproteinemias, Hyper-Low,Disorder, LDL Receptor,Disorders, LDL Receptor,Dominant Hypercholesterolemia, Autosomal,Dominant Hypercholesterolemias, Autosomal,Essential Hypercholesterolemia,Essential Hypercholesterolemias,Familial Combined Hyperlipoproteinemias,Familial Hypercholesterolemia,Familial Hypercholesterolemias,Familial Hypercholesterolemic Xanthomatoses,Familial Hypercholesterolemic Xanthomatosis,Hyper Low Density Lipoproteinemia,Hyper beta Lipoproteinemia,Hyper-Low Density Lipoproteinemias,Hyper-Low-Density-Lipoproteinemias,Hyper-beta-Lipoproteinemias,Hyperbetalipoproteinemias,Hypercholesterolemias, Autosomal Dominant,Hypercholesterolemias, Essential,Hypercholesterolemias, Familial,Hypercholesterolemic Xanthomatoses, Familial,Hyperlipoproteinemia Type 2s,Hyperlipoproteinemia Type IIas,Hyperlipoproteinemia Type IIbs,Hyperlipoproteinemia Type IIs,Hyperlipoproteinemia, Familial Combined,Hyperlipoproteinemias, Familial Combined,Hyperlipoproteinemias, Type II,Hyperlipoproteinemias, Type IIa,LDL Receptor Disorders,Lipoproteinemia, Hyper-Low Density,Lipoproteinemias, Hyper-Low Density,Receptor Disorder, LDL,Receptor Disorders, LDL,Type 2, Hyperlipoproteinemia,Type II Hyperlipoproteinemia,Type II Hyperlipoproteinemias,Type IIa Hyperlipoproteinemia,Type IIa Hyperlipoproteinemias,Xanthomatoses, Familial Hypercholesterolemic,Xanthomatosis, Familial Hypercholesterolemic
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

N de Bont, and T B Geijtenbeek, and M G Netea, and T J Smilde, and P N Demacker, and C G Figdor, and J W Van Der Meer, and A F Stalenhoef
Prolactin stimulates integrin-mediated adhesion of circulating mononuclear cells to endothelial cells.
May 2005, Laboratory investigation; a journal of technical methods and pathology,
N de Bont, and T B Geijtenbeek, and M G Netea, and T J Smilde, and P N Demacker, and C G Figdor, and J W Van Der Meer, and A F Stalenhoef
Cholesterol homeostasis in mononuclear leukocytes from patients with familial hypercholesterolemia treated with lovastatin.
January 1989, Arteriosclerosis (Dallas, Tex.),
N de Bont, and T B Geijtenbeek, and M G Netea, and T J Smilde, and P N Demacker, and C G Figdor, and J W Van Der Meer, and A F Stalenhoef
Functional behaviour of mononuclear blood cells from patients with hypercholesterolemia.
February 1992, Thrombosis research,
N de Bont, and T B Geijtenbeek, and M G Netea, and T J Smilde, and P N Demacker, and C G Figdor, and J W Van Der Meer, and A F Stalenhoef
[Characterization of LDL receptors in mononuclear cells of healthy probands and patients with familial hypercholesterolemia].
January 1992, Wiener klinische Wochenschrift,
N de Bont, and T B Geijtenbeek, and M G Netea, and T J Smilde, and P N Demacker, and C G Figdor, and J W Van Der Meer, and A F Stalenhoef
Effects of hypolipidemic therapy on cholesterol homeostasis in freshly isolated mononuclear cells from patients with heterozygous familial hypercholesterolemia.
December 1983, Proceedings of the National Academy of Sciences of the United States of America,
N de Bont, and T B Geijtenbeek, and M G Netea, and T J Smilde, and P N Demacker, and C G Figdor, and J W Van Der Meer, and A F Stalenhoef
Increased oxidative stress levels and normal antioxidant enzyme activity in circulating mononuclear cells from patients of familial hypercholesterolemia.
February 2010, Metabolism: clinical and experimental,
N de Bont, and T B Geijtenbeek, and M G Netea, and T J Smilde, and P N Demacker, and C G Figdor, and J W Van Der Meer, and A F Stalenhoef
[In vitro cell adhesion and integrin expression by calcium ionophore-treated mononuclear cells from patients with acute myeloid leukemia].
January 2004, Tsitologiia,
N de Bont, and T B Geijtenbeek, and M G Netea, and T J Smilde, and P N Demacker, and C G Figdor, and J W Van Der Meer, and A F Stalenhoef
alpha4beta1 integrin-mediated adhesion of CD34+ cells from patients with chronic myeloid leukaemia: influence of IL-3.
August 1999, British journal of haematology,
N de Bont, and T B Geijtenbeek, and M G Netea, and T J Smilde, and P N Demacker, and C G Figdor, and J W Van Der Meer, and A F Stalenhoef
Circulating progenitor cells in patients with familial hypercholesterolemia.
June 2018, Journal of clinical apheresis,
N de Bont, and T B Geijtenbeek, and M G Netea, and T J Smilde, and P N Demacker, and C G Figdor, and J W Van Der Meer, and A F Stalenhoef
Adenovirus-mediated correction of the genetic defect in hepatocytes from patients with familial hypercholesterolemia.
September 1993, Somatic cell and molecular genetics,
Copied contents to your clipboard!